Allstate (NYSE:ALL – Free Report) had its price objective boosted by Keefe, Bruyette & Woods from $235.00 to $243.00 in a research note issued to investors on Friday,Benzinga reports. Keefe, Bruyette & Woods currently has an outperform rating on the insurance provider’s stock.
Other equities analysts have also issued research reports about the stock. UBS Group boosted their target price on shares of Allstate from $216.00 to $225.00 and gave the company a “buy” rating in a report on Monday, November 4th. Evercore ISI raised Allstate from an “in-line” rating to an “outperform” rating in a research note on Wednesday, January 8th. Raymond James boosted their price target on Allstate from $205.00 to $220.00 and gave the company a “strong-buy” rating in a research note on Friday, October 4th. Morgan Stanley raised their price objective on shares of Allstate from $220.00 to $228.00 and gave the stock an “overweight” rating in a research report on Thursday, November 7th. Finally, Bank of America increased their target price on shares of Allstate from $216.00 to $233.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. One analyst has rated the stock with a sell rating, one has issued a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $218.06.
View Our Latest Stock Report on Allstate
Allstate Stock Down 5.6 %
Allstate (NYSE:ALL – Get Free Report) last posted its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $3.91 EPS for the quarter, topping analysts’ consensus estimates of $2.20 by $1.71. The company had revenue of $16.63 billion for the quarter, compared to analyst estimates of $14.57 billion. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The firm’s quarterly revenue was up 14.7% on a year-over-year basis. During the same period in the previous year, the firm earned $0.81 earnings per share. Analysts predict that Allstate will post 16.26 earnings per share for the current year.
Allstate Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Thursday, January 2nd. Investors of record on Friday, November 29th were issued a dividend of $0.92 per share. The ex-dividend date was Friday, November 29th. This represents a $3.68 dividend on an annualized basis and a yield of 2.03%. Allstate’s dividend payout ratio (DPR) is presently 23.83%.
Hedge Funds Weigh In On Allstate
A number of institutional investors and hedge funds have recently added to or reduced their stakes in ALL. Private Advisor Group LLC raised its holdings in Allstate by 5.9% during the 2nd quarter. Private Advisor Group LLC now owns 12,906 shares of the insurance provider’s stock valued at $2,061,000 after acquiring an additional 717 shares during the period. Prudential PLC grew its stake in Allstate by 46.6% during the second quarter. Prudential PLC now owns 4,285 shares of the insurance provider’s stock valued at $684,000 after acquiring an additional 1,363 shares in the last quarter. Choreo LLC boosted its holdings in Allstate by 258.3% in the 2nd quarter. Choreo LLC now owns 6,725 shares of the insurance provider’s stock valued at $1,079,000 after purchasing an additional 4,848 shares during the period. LPL Financial LLC grew its position in shares of Allstate by 9.2% during the 2nd quarter. LPL Financial LLC now owns 200,939 shares of the insurance provider’s stock valued at $32,082,000 after purchasing an additional 16,846 shares in the last quarter. Finally, Qsemble Capital Management LP bought a new position in shares of Allstate in the second quarter worth $688,000. Institutional investors own 76.47% of the company’s stock.
Allstate Company Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
See Also
- Five stocks we like better than Allstate
- Overbought Stocks Explained: Should You Trade Them?
- ServiceTitan Made Waves in Its IPO, But Is the Stock a Buy?
- What Makes a Stock a Good Dividend Stock?
- Netflix: Is This the Perfect Time to Buy a Streaming Powerhouse?
- With Risk Tolerance, One Size Does Not Fit All
- Goldman Sachs Unveils 3 Massive Opportunities for 2025 Investors
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.